Quorum Innovations competitorsClear all
Quorum Innovations's top competitors include Fulcrum Therapeutics, Vitrolife, Novadip Biosciences and Cell Genesys.
 Quorum Innovations Quorum Innovations develops human microbiome therapeutics designed to treat diseases of tissue barrier deficiency. |  Fulcrum Therapeutics We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are. |  Vitrolife Vitrolife is a biotechnology company that develops products to counter fertility issues in humans. |  Cell Genesys Here at Cell Genesys, we bring you the latest health news on gene therapy, vaccination, and other health related issues the world is facing today. | ||
Founding Date | Founding Date 2010 | Founding Date 2016 | Founding Date 1981 | Founding Date 2013 | Founding Date 1988 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Sarasota, US HQ | Locations Cambridge, US HQ | Locations Västra Frölunda, SE HQ | Locations Mont-Saint-Guibert, BE HQ | Locations Roosevelt, US HQ |
Employees | Employees 3 | Employees 43223% increase | Employees 1,171 | Employees 47 | Employees 911% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 335.7 m | Valuation ($) 3.1 b | Valuation ($) N/A | Valuation ($) N/A |
Twitter followers | Twitter followers 27 | Twitter followers 655 | Twitter followers 1.9 k | Twitter followers N/A | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 16 | Number of tweets (last 30 days) 9 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 2.9 | Average likes per tweet (last 30 days) 1.4 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 87.5% | Percentage of tweets with engagement (last 30 days) 66.67% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank N/A | Alexa Website Rank 266930 | Alexa Website Rank 396872 | Alexa Website Rank N/A | Alexa Website Rank N/A |
Employee Rating | Employee Rating N/A | Employee Rating 4 | Employee Rating 3.7 | Employee Rating N/A | Employee Rating 4 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $8.8m (FY, 2020) | Revenue (est.) kr1.7b (FY, 2021) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($70.8m) (FY, 2020) | Net income kr343.6m (FY, 2021) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 55m | Total funding raised N/A | Total funding raised $ 31.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Fulcrum Therapeutics
HQ
Cambridge, US
Employees
432↑ 23% increase
We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are.
View companyVitrolife
HQ
Västra Frölunda, SE
Employees
1,171
Vitrolife is a biotechnology company that develops products to counter fertility issues in humans.
View company
Novadip Biosciences
HQ
Mont-Saint-Guibert, BE
Employees
47
Novadip Biosciences is a biopharmaceutical company.
View companyCell Genesys
HQ
Roosevelt, US
Employees
91↓ 1% decrease
Here at Cell Genesys, we bring you the latest health news on gene therapy, vaccination, and other health related issues the world is facing today.
View company